{"id":2699,"date":"2026-03-06T11:03:49","date_gmt":"2026-03-06T11:03:49","guid":{"rendered":"https:\/\/thyroidaware.azinova.uk\/mood-disorders\/"},"modified":"2026-06-09T03:40:23","modified_gmt":"2026-06-09T03:40:23","slug":"mood-disorders","status":"publish","type":"page","link":"https:\/\/thyroidaware.azinova.uk\/pl\/mood-disorders\/","title":{"rendered":"ZABURZENIA NASTROJU"},"content":{"rendered":"<div class=\"lazyblock-health-block-Z1NSxOl wp-block-lazyblock-health-block\"><div class=\"heading-detail\">\n      <p>TWOJE\u00a0 ZDROWIE<\/p>\n<h1>ZABURZENIA NASTROJU<\/h1>  <\/div>\n<div class=\"detail\">\n  <div class=\"detail-heading\">\n          <h2 class=\"wp-block-heading has-electviolet-color has-text-color\">NIEPRAWID\u0141OWA CZYNNO\u015a\u0106 TARCZYCY A ZABURZENIA NASTROJU<\/h2>\n<p class=\"wp-block-heading has-electviolet-color has-text-color\">Pacjenci z zaburzeniami czynno\u015bci tarczycy cz\u0119sto skar\u017c\u0105 si\u0119 na problemy z nastrojem i funkcjami poznawczymi<sup>1<\/sup>. Ju\u017c w 1825 roku C. H. Parry opisa\u0142 zale\u017cno\u015b\u0107 mi\u0119dzy zaburzeniami czynno\u015bci tarczycy i problemami z nastrojem<sup>1<\/sup>.\u00a0<\/p>      <\/div>\n  \n<div class=\"parent\">\n\t<div class=\"share-wrapper mb\">\n\n\t\t<div class=\"social-container\" id=\"socialBox\">\n\n\t\t\t<a id=\"facebookShare\" target=\"_blank\">\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/themes\/thyroidaware\/images\/facebook-share.svg\" alt=\"Facebook\">\n\t\t\t<\/a>\n\n\t\t\t<a id=\"linkedinShare\" target=\"_blank\">\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/themes\/thyroidaware\/images\/linkedin-share.svg\" alt=\"LinkedIn\">\n\t\t\t<\/a>\n\n\t\t\t<a id=\"whatsappShare\" target=\"_blank\">\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/themes\/thyroidaware\/images\/whatsapp-share.svg\" alt=\"WhatsApp\">\n\t\t\t<\/a>\n\n\t\t\t<a id=\"emailShare\">\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/themes\/thyroidaware\/images\/email-share.svg\" alt=\"Email\">\n\t\t\t<\/a>\n\n\t\t\t<a href=\"#\" id=\"copyLink\" data-copied=\"Link copied!\">\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/themes\/thyroidaware\/images\/link-share.svg\" alt=\"Copy Link\">\n\t\t\t<\/a>\n\n\t\t<\/div>\n\t\t<div class=\"share-btn\" id=\"shareBtn\">\n\t\t\t<span>UDZIA\u0141<\/span>\n\t\t\t<img decoding=\"async\" class=\"share-btn-detail-page\" src=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/themes\/thyroidaware\/images\/share-icon.png\" alt=\"\">\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n      <p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-369 size-full\" src=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/uploads\/2026\/03\/mood-disorder.webp\" alt=\"\" width=\"966\" height=\"644\" srcset=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/uploads\/2026\/03\/mood-disorder.webp 966w, https:\/\/thyroidaware.azinova.uk\/wp-content\/uploads\/2026\/03\/mood-disorder-300x200.webp 300w, https:\/\/thyroidaware.azinova.uk\/wp-content\/uploads\/2026\/03\/mood-disorder-768x512.webp 768w\" sizes=\"auto, (max-width: 966px) 100vw, 966px\" \/><\/p>\n<h3><strong>Cz\u0119sto wyst\u0119puj\u0105ce objawy<\/strong><\/h3>\n<p>Niekt\u00f3re objawy zaburze\u0144 czynno\u015bci tarczycy s\u0105 podobne do objaw\u00f3w obserwowanych w depresji lub zaburzeniach l\u0119kowych. Do objaw\u00f3w najcz\u0119\u015bciej zwi\u0105zanych z niedoczynno\u015bci\u0105 tarczycy nale\u017c\u0105 zapominanie, zm\u0119czenie, spowolnienie umys\u0142owe i nieuwaga oraz wahania nastroju, przy czym dominuj\u0105cym objawem jest przygn\u0119bienie<sup>2<\/sup>. Niepok\u00f3j, rozdra\u017cnienie, dysforia, wahania nastroju i problemy z koncentracj\u0105 s\u0105 typowymi objawami towarzysz\u0105cymi nadczynno\u015bci tarczycy<sup>1<\/sup>. U tych os\u00f3b obserwuje si\u0119 r\u00f3wnie\u017c spadek libido<sup>3<\/sup>.<\/p>\n<h3><strong>Poznaj fakty<\/strong><\/h3>\n<p>Oko\u0142o 60% os\u00f3b z nadczynno\u015bci\u0105 tarczycy prezentuje zaburzenia l\u0119kowe, a 31\u201369% depresyjne<sup>1<\/sup>. Depresj\u0119 cz\u0119sto obserwuje si\u0119 r\u00f3wnie\u017c u pacjent\u00f3w z niedoczynno\u015bci\u0105 tarczycy, a 40% chorych potwierdza w wywiadzie obecno\u015b\u0107 jednej z postaci zaburze\u0144 depresyjnych<sup>2<\/sup>.<\/p>\n<p>U 1\u20134% pacjent\u00f3w z zaburzeniami nastroju stwierdza si\u0119 niedoczynno\u015b\u0107 tarczycy, a subkliniczn\u0105 posta\u0107 tej choroby stwierdza si\u0119 u 4\u201340% os\u00f3b w tej grupie<sup>1<\/sup>. Dlatego te\u017c Ameryka\u0144skie Towarzystwo Endokrynologii Klinicznej i Ameryka\u0144skie Towarzystwo Tyreologiczne zalecaj\u0105, aby: \u201eU ka\u017cdego pacjenta z depresj\u0105 rozwa\u017cy\u0107 przeprowadzenie diagnostyki w kierunku subklinicznej lub jawnej niedoczynno\u015bci tarczycy<sup>1<\/sup>\u201d.<\/p>\n<h3><strong>Leczenie zaburze\u0144 nastroju<\/strong><\/h3>\n<p>Osoby z nadczynno\u015bci\u0105 lub niedoczynno\u015bci\u0105 tarczycy s\u0105 zagro\u017cone wyst\u0105pieniem pewnej postaci zaburze\u0144 l\u0119kowych i depresji<sup>1<\/sup>. W przypadku niedoczynnej tarczycy istnieje wi\u0119ksze ryzyko rozwoju depresji<sup>2<\/sup>. Dobra wiadomo\u015b\u0107 jest taka, \u017ce u wi\u0119kszo\u015bci pacjent\u00f3w zaburzenia nastroju i problemy poznawcze ust\u0119puj\u0105 podczas skutecznego leczenia choroby tarczycy<sup>2,4<\/sup>. Je\u015bli chorujesz na niedoczynno\u015b\u0107 tarczycy, prawdopodobnie lekarz przepisze ci lek, kt\u00f3ry pozwoli unormowa\u0107 prac\u0119 narz\u0105du<sup>5<\/sup>. Je\u015bli masz nadczynno\u015b\u0107 tarczycy, zostanie ci zaproponowana jedna z nast\u0119puj\u0105cych opcji leczenia: leki przeciwtarczycowe, leczenie radiojodem lub operacyjne usuni\u0119cie cz\u0119\u015bci albo ca\u0142o\u015bci tarczycy<sup>5<\/sup>. U wi\u0119kszo\u015bci pacjent\u00f3w, po unormowaniu st\u0119\u017ce\u0144 hormon\u00f3w tarczycowych, objawy l\u0119kowe i depresyjne ust\u0119puj\u0105<sup>2<\/sup>.<\/p>  \n\n      <div class=\"reference-toggle\">\n      <div class=\"ref-header1\" id=\"refToggle\">\n        <span>PI\u015aMIENNICTWO<\/span>\n        <img decoding=\"async\" class=\"refimg\" id=\"refIcon\" src=\"https:\/\/thyroidaware.azinova.uk\/wp-content\/themes\/thyroidaware\/images\/ref-close.webp\" alt=\"\">\n      <\/div>\n\n      <div class=\"ref-content\" id=\"refContent\">\n        <ul>\n<li>Hage MP, Azar ST. The link between thyroid function and depression. J Thyroid Res 2012; 2012: 590648<\/li>\n<li>Heinrich TW, Graham G. Hypothyroidism presenting as psychosis: myxedema madness revisited. Prim Care Companion J Clin Psychiatry 2003; 5: 260\u2013266<\/li>\n<li>Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31: 702\u201375<\/li>\n<li>Bov\u00e9 KB, Watt T, Vogal A et al. Anxiety and depression are more prevalent in patients with Graves\u2019 disease than in patients with nodular goiter. Eur Thyroid J 2014; 3: 173\u2013178<\/li>\n<li>American Thyroid Association. Hyperthyroidism. 2014. Available at\u00a0<a href=\"http:\/\/www.thyroid.org\/wp-content\/uploads\/patients\/brochures\/ata-hyperthyroidism-brochure.pdf\">http:\/\/www.thyroid.org\/wp-content\/uploads\/patients\/brochures\/ata-hyperthyroidism-brochure.pdf<\/a>. Last accessed February 2022<\/li>\n<\/ul>      <\/div>\n    <\/div>\n  \n      <section class=\"container-fluid\">\n<section id=\"post-161\" class=\"row articulos\">\n<section class=\"col-12 offset-lg-3 col-lg-6 position-relative\">\n<section class=\"editor-content-custom\">\n<section class=\"container-fluid\">\n<section class=\"row articulos\">\n<section class=\"col-12 offset-lg-3 col-lg-6 position-relative\">\n<section class=\"editor-content-custom\">\n<h4>PL-NONT-00093<\/h4>\n<h4><strong>Data opracowania: Maj 2026 r.<\/strong><\/h4>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<footer class=\"container-fluid mt-auto\">\n<section class=\"row\">\n<section class=\"col-12 offset-lg-2 col-lg-8 mt-5\">\n<section class=\"d-flex justify-content-between align-items-start align-items-lg-center flex-column flex-lg-row my-5\"><\/section>\n<\/section>\n<\/section>\n<\/footer><\/section>\n<\/section>\n<\/section>\n<\/section>\n<footer class=\"container-fluid mt-auto\">\n<section class=\"row\">\n<section class=\"col-12 offset-lg-2 col-lg-8 mt-5\">\n<section class=\"d-flex justify-content-between align-items-start align-items-lg-center flex-column flex-lg-row my-5\"><\/section>\n<\/section>\n<\/section>\n<\/footer>  \n<\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"page-templates\/page-health.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2699","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/thyroidaware.azinova.uk\/pl\/wp-json\/wp\/v2\/pages\/2699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thyroidaware.azinova.uk\/pl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/thyroidaware.azinova.uk\/pl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/thyroidaware.azinova.uk\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thyroidaware.azinova.uk\/pl\/wp-json\/wp\/v2\/comments?post=2699"}],"version-history":[{"count":5,"href":"https:\/\/thyroidaware.azinova.uk\/pl\/wp-json\/wp\/v2\/pages\/2699\/revisions"}],"predecessor-version":[{"id":5366,"href":"https:\/\/thyroidaware.azinova.uk\/pl\/wp-json\/wp\/v2\/pages\/2699\/revisions\/5366"}],"wp:attachment":[{"href":"https:\/\/thyroidaware.azinova.uk\/pl\/wp-json\/wp\/v2\/media?parent=2699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}